CINECA IRIS Institutional Research Information System

MARTINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.317
EU - Europa 1.450
AS - Asia 1.276
SA - Sud America 126
AF - Africa 37
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.261
CN - Cina 666
IT - Italia 448
SG - Singapore 191
DE - Germania 131
FR - Francia 130
IE - Irlanda 119
SE - Svezia 108
ES - Italia 96
GB - Regno Unito 82
IN - India 71
AT - Austria 68
BR - Brasile 55
KR - Corea 48
BE - Belgio 47
JP - Giappone 47
TR - Turchia 38
CA - Canada 37
HK - Hong Kong 36
ID - Indonesia 36
UA - Ucraina 36
FI - Finlandia 32
AR - Argentina 30
VN - Vietnam 30
EG - Egitto 24
PL - Polonia 22
RU - Federazione Russa 22
NL - Olanda 21
CO - Colombia 17
PT - Portogallo 17
TW - Taiwan 17
MX - Messico 16
GR - Grecia 15
TH - Thailandia 14
AU - Australia 13
CL - Cile 13
PH - Filippine 12
RO - Romania 11
CH - Svizzera 10
DK - Danimarca 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
IL - Israele 9
PE - Perù 8
PK - Pakistan 8
MY - Malesia 7
IR - Iran 6
MM - Myanmar 6
BA - Bosnia-Erzegovina 5
LB - Libano 5
NO - Norvegia 5
CM - Camerun 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
EC - Ecuador 3
EU - Europa 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
SN - Senegal 2
SV - El Salvador 2
BG - Bulgaria 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 5.223
Salva come PNG Salva come JPEG
Città #
Chandler 358
Santa Clara 246
Beijing 186
Singapore 159
Dublin 119
Fairfield 103
Nyköping 75
Ann Arbor 70
Fremont 69
Vienna 62
Torino 59
Villeurbanne 53
Houston 50
Ashburn 49
Dearborn 49
Columbus 48
Redwood City 48
Cambridge 46
Woodbridge 46
Hangzhou 44
New York 42
Medford 40
Wilmington 40
Princeton 39
Turin 39
Milan 37
Rome 37
Guangzhou 36
Shanghai 36
Jakarta 31
Jacksonville 27
Pisa 27
Brussels 26
Barcelona 22
Paris 22
Hebei 19
Los Angeles 19
Seattle 19
Boston 18
Chengdu 17
Delhi 17
Chongqing 16
Nanjing 16
Tokyo 16
Hanover 15
São Paulo 15
Warsaw 15
Buenos Aires 14
Istanbul 14
London 14
Berlin 13
Bologna 13
Dong Ket 13
Madrid 12
Toronto 12
Wuhan 12
Central 11
Hefei 11
Osaka 11
Rimini 11
Seoul 11
Cairo 10
Helsinki 10
Tianjin 10
Chicago 9
Hong Kong 9
Kunming 9
Mumbai 9
Nanning 9
Taipei 9
Washington 9
Copenhagen 8
Kiel 8
San Diego 8
Upper Marlboro 8
Birmingham 7
Bordeaux 7
Kuala Lumpur 7
Lima 7
Moscow 7
Ottawa 7
Padova 7
Qingdao 7
Santiago 7
Athens 6
Fuzhou 6
Gent 6
Giza 6
Jena 6
Medellín 6
Monza 6
Naples 6
Norwalk 6
Recife 6
Rotterdam 6
Seville 6
Xian 6
Boardman 5
Bursa 5
Changsha 5
Totale 3.095
Salva come PNG Salva come JPEG
Nome #
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 1.721
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 318
Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model 281
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 159
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 127
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 118
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 117
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 116
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 111
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 108
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 106
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 97
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 97
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 96
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 92
Successful urgent liver retransplantation for donor-transmitted hepatocellular carcinoma 91
IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS 90
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 87
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 86
Early and Late Hepatitis B Reactivation after IFN- or DAA-based Therapy of Recurrent Hepatitis C in Anti-HBc-positive Liver Transplant Recipients 83
Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience 83
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? 80
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 79
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? 79
Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters 77
Urgent liver transplantation soon after recovery from COVID-19 in a patient with decompensated liver cirrhosis 76
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals? 75
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease 75
Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period 73
Reply to: Seroconversion after COVID-19 vaccination (LT-21-741) 73
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection 72
SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 70
Severe Passenger Lymphocyte Syndrome and Acute Rejection in ABO Compatible but non-Identical Liver Transplant Recipient from Hepatitis C Viremic Donor 54
Extracellular Vesicles in Liver Transplantation: Current Evidence and Future Challenges 39
Seroprevalence of Hepatitis E Virus in liver transplant patients in Turin, Italy. 39
Early post-liver transplant use of direct-acting antivirals in naive and NS5A inhibitor-experienced HCV patients 32
Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work? 31
Solid non-lung organs from COVID-19 donors in seropositive or naive recipients: Where do we stand? 30
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS) 29
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients 29
Favorable experience of transplant strategy including liver grafts from COVID-19 donors: One-year follow-up results 23
Functional evaluation of right coronary artery with anomalous origin in cirrhotic liver transplant candidate 22
Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up 17
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 12
Fecal microbiota transplantation before liver transplant in patient colonized with New Delhi metallo-beta-lactamase: Are we ready for a sequential approach? 11
Totale 5.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.461
article - articoli 0
book - libri 0
conference - conferenze 4.129
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 0 0 0 0 0 0 39 29 29 34 23 21
2020/2021424 19 27 13 12 21 26 36 36 40 38 63 93
2021/2022952 60 44 70 51 118 109 54 57 52 62 142 133
2022/20231.188 100 107 75 106 80 203 64 116 119 52 101 65
2023/2024847 93 90 65 47 84 106 63 56 27 61 70 85
2024/2025910 41 121 85 161 336 137 29 0 0 0 0 0
Totale 5.381